NewsRx

Search our medical news database

Antisense Technology

ODNs May Offer Alternative Antimalarial Strategy

Published in Gene Therapy Weekly, February 19th, 1996

The use of antisense oligodeoxynucleotides could offer a way to identify essential malaria genes as potential targets for drug development

In addition, the methodology for identifying essential genes is necessary for the development of other drugs as well, indicated Robert H. Barker, Jr., and colleagues from Hybridon, Inc. and Worcester Foundation for Biomedical Research, Worcester, Massachusetts.

Barker et al. used antisense (AS) oligodeoxynucleotides (ODNs) against various target genes to study growth inhibition of Plasmodium falciparum in in vitro culture ("Inhibition of Plasmodium falciparum Malaria Using Antisense...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook